Skip to main content
. 2021 Nov 23;14:8689–8710. doi: 10.2147/IJGM.S338284

Figure 9.

Figure 9

mDNAsi/mRNAsi associated with CSMD1 mutant status and clinicopathological characteristics. (A and B) Differences in mDNAsi/mRNAsi between tumor and normal group. (C and D) Differences in mDNAsi/mRNAsi between the CSMD1 mutant group and the wild group. (E/F) Differences in mDNAsi/mRNAsi between different subtypes of each clinicopathological.